Clinical Trial Update: Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial compares nilotinib to imatinib as first-line therapy for Philadelphia chromosome-positive chronic myeloid leukemia in Chinese patients with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Tasigna (nilotinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2015-12-09